Company Profile

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8038.65-59.2 (-0.73 % )
PREV CLOSE (Rs.) 8097.85
OPEN PRICE (Rs.) 8090.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1100
TODAY'S LOW / HIGH (Rs.)7995.00 8177.95
52 WK LOW / HIGH (Rs.)7322.1 8999
NSE8034.00 -60.2 (-0.74 % )
PREV CLOSE(Rs.) 8094.20
OPEN PRICE (Rs.) 8100.00
BID PRICE (QTY) 8034.00 (10 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 31163
TODAY'S LOW / HIGH(Rs.) 7990.00 8176.95
52 WK LOW / HIGH (Rs.)7306 8989

Company News

Date Heading Details
14-Apr-2021 Sanofi India informs about board meeting <p align="justify">Sanofi India has informed about board meeting.<br></p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
07-Apr-2021 Sanofi India informs about certificate <p align="justify">Sanofi India has informed that the Link Intime India, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st March 2021 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.</p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>
17-Mar-2021 Sanofi India informs about investor webinar presentation <P align=justify>With reference to letter dated 24th February 2021 intimating the details of the investor webinar which was scheduled today; Sanofi India has informed that the presentation made by the Company at the investor webinar is enclosed for reference under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<P align=justify>The above information is a part of company's filings submitted to BSE.
23-Feb-2021 Announcement under Regulation 30 (LODR)-Dividend Updates Outcome of Board Meeting - Final Dividend, Special Dividend, Annual General Meeting (AGM) Date & Book Closure Date as per enclosed file
23-Feb-2021 Announcement under Regulation 30 (LODR)-Dividend Updates Outcome of Board Meeting - Final Dividend, Special Dividend, Annual General Meeting (AGM) Date & Book Closure Date as per enclosed file
23-Feb-2021 Appointment / Re-Appointment Of Directors, Re-Appointment Of Chairman The Board of Directors of the Company at its Meeting held today, based on recommendation of the Nomination and Remuneration Committee approved the appointment / re-appointment of the following Directors: 1. Re-appointment of Mr. Aditya Narayan as an Independent Director and Chairman 2. Re-appointment of Ms. Usha Thorat as an Independent Director 3. Appointment of Mr. Vaibhav Karandikar as Additional Director and Whole Time Director
23-Feb-2021 Appointment / Re-Appointment Of Directors, Re-Appointment Of Chairman The Board of Directors of the Company at its Meeting held today, based on recommendation of the Nomination and Remuneration Committee approved the appointment / re-appointment of the following Directors: 1. Re-appointment of Mr. Aditya Narayan as an Independent Director and Chairman 2. Re-appointment of Ms. Usha Thorat as an Independent Director 3. Appointment of Mr. Vaibhav Karandikar as Additional Director and Whole Time Director
08-Feb-2021 Sanofi India informs about board meeting <p align="justify">Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on 23rd February 2021, to approve the audited accounts for the year ended 31st December 2020 and recommend final dividend for the period mentioned above.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
08-Feb-2021 Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 23Rd February 2021. Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2021 ,inter alia, to consider and approve Dear Sirs, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on 23rd February 2021; inter alia to: Approve the audited accounts for the year ended 31st December 2020. Recommend final dividend for the period mentioned above.
08-Feb-2021 Board to consider FY20 results & Final Dividend on February 23, 2021 Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 23, 2021, inter alia, to: 1. Approve the audited accounts for the year ended December 31, 2020. 2. Recommend final dividend for the period mentioned above.